Macroaxis is not in business of monitoring VanEck Vectors headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with VanEck Vectors Biotech ETF brand which may create opportunities for some arbitrage if properly timed. With VanEck Vectors hype-based prediction module you can estimate the value of VanEck Vectors Biotech ETF from the prospective of VanEck Vectors response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on VanEck Vectors over a specific investment horizon. Check also VanEck Vectors Basic Forecasting Models to cross-verify your projections.
On 22 of June VanEck Vectors Biotech ETF is traded for 122.09. This company stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. VanEck Vectors Biotech ETF is estimated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is estimated to be very small where as daily expected return is currently at 0.16%. The volatility of relative hype elasticity to VanEck Vectors is about 1327.87%%. The volatility of related hype on VanEck Vectors is about 1327.87% with expected price after next announcement by competition of 122.08. The company had not issued any dividends in recent years. Considering 30-days investment horizon, the next estimated press release will be in 5 to 10 days. Check also VanEck Vectors Basic Forecasting Models to cross-verify your projections.